openPR Logo
Press release

Autologous Matrix-induced Chondrogenesis Market Analysis & Growth Forecast for the period 2016-2024

05-31-2017 12:03 PM CET | Health & Medicine

Press release from: Industry Analysis Reports - MRRSE

MRRSE

MRRSE

With an increase in the count of bone and joint disorders on a global level, the need for an efficient biological treatment has become quite necessary. This requirement has led to the growth of the Autologous Matrix-induced Chondrogenesis market. To study further, the latest report focusing on this particular treatment option has been added to the vast repository of Market Research Reports Search Engine (MRRSE). The report is titled, “Autologous Matrix-induced Chondrogenesis Market- Global Industry Analysis, Size, Share, Growth, Trends and Forecast 2016-2024”, which analyzes the current as well as future prospects of this sector for the forecast period 2016-2024.

Request Sample Report : http://www.mrrse.com/sample/2495

Autologous Matrix-Induced Chondrogenesis (AMIC) is an advanced biological surgical procedure developed for the treatment of osteochondral lesions and traumatic chondral. The well-designed principle of microfracturing is grounded on the release of multipotent mesenchymal progenitor cells, growth factors and cytokines from the subchondral bone. The global autologous matrix-induced chondrogenesis market was valued at US$89.71 mn in the year 2015 and is projected to be worth US$186.38 mn by 2024. Also, the growth rate between 2016 and 2024, in the global market is assumed to progress at a CAGR of 8.6%.

The market for Autologous Matrix-Induced Chondrogenesis has been experiencing significant growth, which is analyzed in the initial section of the report focused towards the market dynamics. Increasing demand for minimally invasive procedures, ageing population, surge in sports injuries etc, are analyzed as the top drivers. Moreover, the readers can also gain details regarding the restraints which include lack of extensive clinical data and efficient reimbursement system. Furthermore, market opportunities along with Porter’s five forces analysis, value chain analysis and global AMIC market revenue projection are precisely stated in the research study.

In the later section, segmentation of the market based on material type has been clearly stated. The mentioned materials include:

Hyaluronic Acid
Polyethylene Glycol (PEG)
Collagen
Poly lactic-co-glycolic acid (PGLA
Others
Further, on the basis of geographical aspect, the global market has been segregated into five regions, namely, North America, Latin America, Asia Pacific, Europe and Middle East & Africa. Also, the regions have been further dissected by major countries for each of the above stated areas. These include the U.S., U.K., Canada, Germany, Italy, France, Spain, Japan, China, India, UAE, Saudi Arabia, Brazil, and Mexico.

Browse Full Report with TOC :http://www.mrrse.com/autologous-matrix-induced-chondrogenesis-market

In the concluding section of the report, the readers can access details related to the top players from the AMIC market. Key companies profiled in the report include Anika Therapeutics Inc., B. Braun Melsungen AG, Arthro-Kinetics, CartiHeal, BioTissue AG, JRI Orthopaedics Ltd., Geistlich Pharma AG, Smith & Nephew plc, Matricel GmbH and Zimmer Biomet Holdings. Each of these players are analyzed on the basis of various attributes such as company overview, SWOT analysis, financial overview, product portfolio, key business strategies and recent developments.

Market Research Reports Search Engine (MRRSE) is an industry-leading database of market intelligence reports. MRRSE is driven by a stellar team of research experts and advisors trained to offer objective advice. Our sophisticated search algorithm returns results based on the report title, geographical region, publisher, or other keywords.

MRRSE partners exclusively with leading global publishers to provide clients single-point access to top-of-the-line market research. MRRSE’s repository is updated every day to keep its clients ahead of the next new trend in market research, be it competitive intelligence, product or service trends or strategic consulting.

State Tower
90, State Street
Suite 700
Albany, NY - 12207
United States
Telephone: +1-518-730-0559
Email: sales@mrrse.com
Google+: https://plus.google.com/u/0/109558601025749677847/posts
Linked in: https://www.linkedin.com/company/mrrse
Twitter: https://twitter.com/MRRSEmrrse

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Autologous Matrix-induced Chondrogenesis Market Analysis & Growth Forecast for the period 2016-2024 here

News-ID: 557890 • Views:

More Releases for Autologous

Transformative Trends Impacting the Autologous Cell Therapy Market Landscape: Te …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts. How Large Will the Autologous Cell Therapy Market Size By 2025? The market size for autologous cell therapy has seen a swift expansion in the past few years. The growth is projected to increase from $10.28 billion in 2024 to $12.19 billion in 2025, at a compound annual growth
Emerging Trends Influencing The Growth Of The Autologous Cell Therapy Market:Tec …
The Autologous Cell Therapy Market Report by The Business Research Company delivers a detailed market assessment, covering size projections from 2025 to 2034. This report explores crucial market trends, major drivers and market segmentation by [key segment categories]. How Big Is the Autologous Cell Therapy Market Size Expected to Be by 2034? The Autologous Cell Therapy Market Report by The Business Research Company delivers a detailed market assessment, covering size projections from
Prominent Autologous Stem Cell And Non-Stem Cell Based Therapies Market Trend fo …
What Are the Projected Growth and Market Size Trends for the Autologous Stem Cell And Non-Stem Cell Based Therapies Market? The market size for autologous stem cell and non-stem cell based treatments has experienced rapid expansion in recent years. In numerical terms, it is predicted to rise from $9.96 billion in 2024 to $11.59 billion in 2025, with a compound annual growth rate (CAGR) of 16.5%. The significant growth during the
Autologous Cell Therapy Market Growth Outlook 2027
Transparency Market Research (TMR) has published a new report titled, 'Autologous cell therapy Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2019-2027'. According to the report, the global autologous cell therapy market was valued at US$ 7.5 Bn in 2018 and is projected to expand at a CAGR of 18.1% from 2019 to 2027. Get Sample Copy of the Report @ https://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=715 Overview • Cell therapy also termed as cellular therapy
Autologous Cell Therapy Market Insights Shared in Detailed Report
Transparency Market Research (TMR) has published a new report titled, 'Autologous cell therapy Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2019-2027'. According to the report, the global autologous cell therapy market was valued at US$ 7.5 Bn in 2018 and is projected to expand at a CAGR of 18.1% from 2019 to 2027. Get Sample Copy of the Report @ https://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=715 Overview • Cell therapy also termed as cellular therapy
Autologous Cell Therapy Market: High Prevalence of Cancer Triggers Demand for Au …
Global Autologous Cell Therapy Market: Overview Autologous cell therapy refers to infusion or transfer of human tissue or cells back to the same person for treating a diseased part. For the same purpose, stem cells are removed from the patient, harvested, cultured, and once again transplanted to the same person. The purpose of this method is to reduce the chances of rejection to the treatment by the body. Furthermore, autologous cell